Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article

This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer

Email this article to a friend

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

E Amir, OC Freedman, S Chia, T Petrella, S Dent, K Tonkin, I Ahmad, D Rayson, G Dranitsaris and M Clemons

Breast Cancer Research 2009, 11(Suppl 1):P29 doi:10.1186/bcr2312

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.